AptarGroup (NYSE:ATR) has had a rough three months with its share price down 7.0%. However, a closer look at its ...
Investor's Business Daily on MSN
Stock market today: Nvidia climbs as Dow lags; this quantum name sells off after rally (live coverage)
The Dow eased 0.1% despite Nvidia NVDA picking up momentum with a gain of nearly 2% in recent action. McDonald's MCD and ...
IonQ Inc (NYSE:IONQ) stock is up 7.2% to trade at $49.41 today, after Jefferies initiated coverage on the quantum computing ...
Investing.com -- AstraZeneca PLC (ST:AZN) announced Monday that its LATIFY Phase III trial of ceralasertib in combination ...
Union Aviation Minister Ram Mohan Naidu Kinjarapu highlighted that the government is actively encouraging new airlines to ...
Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path December 15, 2025 11:00 AM ...
In his address, Shri Manohar Lal underscored that timely availability of capital is crucial for completing infrastructure ...
NEWS The proceeds are expected to extend the Company’s cash runway into Q1 2027, with potential inflection points anticipated in its clinical programs during that period ...
Investing.com -- AstraZeneca PLC (NASDAQ:AZN) announced Monday that its LATIFY Phase III trial of ceralasertib failed to meet its primary endpoint in non-small cell lung cancer (NSCLC).
Liberty Defense Holdings Ltd. ("Liberty" or the "Company") , ? a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce ...
Summary • GT Biopharma, Inc. trades at $0.6960, up 5% in pre-market without a clear catalyst.• The stock has gained 8.27% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback